These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23165329)

  • 21. Uncertainty in Antibiotic Dosing in Critically Ill Neonate and Pediatric Patients: Can Microsampling Provide the Answers?
    Dorofaeff T; Bandini RM; Lipman J; Ballot DE; Roberts JA; Parker SL
    Clin Ther; 2016 Sep; 38(9):1961-75. PubMed ID: 27544661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.
    Roberts JA; Abdul-Aziz MH; Lipman J; Mouton JW; Vinks AA; Felton TW; Hope WW; Farkas A; Neely MN; Schentag JJ; Drusano G; Frey OR; Theuretzbacher U; Kuti JL;
    Lancet Infect Dis; 2014 Jun; 14(6):498-509. PubMed ID: 24768475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Piperacillin concentration in relation to therapeutic range in critically ill patients--a prospective observational study.
    Zander J; Döbbeler G; Nagel D; Maier B; Scharf C; Huseyn-Zada M; Jung J; Frey L; Vogeser M; Zoller M
    Crit Care; 2016 Apr; 20():79. PubMed ID: 27039986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute Kidney Injury in the Critically Ill Patient: A Current Review of the Literature.
    Pakula AM; Skinner RA
    J Intensive Care Med; 2016 Jun; 31(5):319-24. PubMed ID: 25752308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adequate anti-infective treatment : Importance of individual dosing and application].
    Brinkmann A; Röhr AC; Köberer A; Fuchs T; Krüger WA; König C; Richter D; Weigand MA; Frey OR
    Anaesthesist; 2018 Jun; 67(6):461-476. PubMed ID: 29766208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosing guidance for intravenous colistin in critically-ill patients.
    Nation RL; Garonzik SM; Thamlikitkul V; Giamarellos-Bourboulis EJ; Forrest A; Paterson DL; Li J; Silveira FP
    Clin Infect Dis; 2017 Mar; 64(5):565-571. PubMed ID: 28011614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Personalised pharmacotherapy in intensive care unit patients].
    Bellmann R
    Med Klin Intensivmed Notfmed; 2017 May; 112(4):289-294. PubMed ID: 28466289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial safety considerations in critically ill patients: part I: focused on acute kidney injury.
    Shahbazi F; Shojaei L; Farvadi F; Kadivarian S
    Expert Rev Clin Pharmacol; 2022 May; 15(5):551-561. PubMed ID: 35734940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic dose optimization in critically ill patients.
    Cotta MO; Roberts JA; Lipman J
    Med Intensiva; 2015 Dec; 39(9):563-72. PubMed ID: 26415688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implications of antibiotic pharmacokinetic principles in the critically ill.
    Udy AA; Roberts JA; Lipman J
    Intensive Care Med; 2013 Dec; 39(12):2070-82. PubMed ID: 24045886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic Dosing in Continuous Renal Replacement Therapy.
    Shaw AR; Mueller BA
    Adv Chronic Kidney Dis; 2017 Jul; 24(4):219-227. PubMed ID: 28778361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
    Roberts DM; Roberts JA; Roberts MS; Liu X; Nair P; Cole L; Lipman J; Bellomo R;
    Crit Care Med; 2012 May; 40(5):1523-8. PubMed ID: 22511133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
    Economou CJP; Kielstein JT; Czock D; Xie J; Field J; Richards B; Tallott M; Visser A; Koenig C; Hafer C; Schmidt JJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2018 Aug; 52(2):151-157. PubMed ID: 29526606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of augmented renal clearance in critically ill patients.
    Udy AA; Roberts JA; Lipman J
    Nat Rev Nephrol; 2011 Jul; 7(9):539-43. PubMed ID: 21769107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.
    Veiga RP; Paiva JA
    Crit Care; 2018 Sep; 22(1):233. PubMed ID: 30244674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Monte Carlo Simulations to Determine Optimal Carbapenem Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.
    Lewis SJ; Kays MB; Mueller BA
    J Clin Pharmacol; 2016 Oct; 56(10):1277-87. PubMed ID: 26919659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?
    Blot S; Lipman J; Roberts DM; Roberts JA
    Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal replacement therapy in critically ill patients: who, when, why, and how.
    Meersch M; Zarbock A
    Curr Opin Anaesthesiol; 2018 Apr; 31(2):151-157. PubMed ID: 29324487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury.
    Bagshaw SM; Darmon M; Ostermann M; Finkelstein FO; Wald R; Tolwani AJ; Goldstein SL; Gattas DJ; Uchino S; Hoste EA; Gaudry S
    Intensive Care Med; 2017 Jun; 43(6):841-854. PubMed ID: 28289816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotics: why they fail in patients who are critically ill.
    Bamberger DM
    Crit Care Nurs Q; 1997 Nov; 20(3):60-8. PubMed ID: 9392757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.